One majority population, with larger cells based on their forward scatter (FSC) profile and expressing low levels of B220, IgD, CD21 and CD23 and high levels of IgM (Figure 1B), corresponds to the CLL/SLL expanded cells (blue). This evidence concerns the gene PTPRC and B-cell chronic lymphocytic leukemia.